Status:
RECRUITING
Characteristics of Hypophosphatasia in Adult Patients in Rheumatology and Their Value in Developing an Algorithm to HPP-diagnosis - the COHIR Multi-center Study
Lead Sponsor:
University of Bonn
Conditions:
Hypophosphatasia
Eligibility:
All Genders
18+ years
Brief Summary
Non-interventional, prospective, multi-center investigation with exploratory data analysis to assess the proportion of patients with hypophosphatasia presenting at departments of rheumatology and to e...
Detailed Description
Acronym: Expansion: HPP =Hypophosphatasia COHIR ="Characteristics of Hypophosphatasia in Adult Patients in Rheumatology" ALPL =Alkaline Phosphatase
Eligibility Criteria
Inclusion
- Written informed consent
- Age \> 18 years
- Clinical suspicion of hypophosphatasia
- Evidence of an abnormal ALP (ALP below LLN) within the clinical routine screening
Exclusion
- Failure to meet the inclusion criteria listed above
Key Trial Info
Start Date :
August 25 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT06574282
Start Date
August 25 2024
End Date
September 1 2027
Last Update
February 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic of Internal Medicine III, Department of Oncology, Haematology, Rheumatology and Clinical Immunology, University Hospital Bonn
Bonn, North Rhine-Westphali, Germany, 53127